Ariad Pharma files ponatinib at EMA for CML and Ph+ALL - 01-Sep-2012

CHMP recomends Iclusig (Ariad Pharma) for CML and Ph+ALL

FDA approves Gleevec (Novartis) to treat Ph+ALL

FDA approves Iclusig(Ariad Pharma) for CML and Ph+ ALL

Ariad Pharma files ponatinib at EMA for CML and Ph+ALL

FDA approves Marqibo (Talon Therapeutics) for Ph-ALL

Ponatinib (Ariad Pharma) filed at FDA for CML and Ph+ALL

Barrx RF Ablation system success in Barrett's Oesophagus

Study shows NeuroStar TMS (Neuronetics) successful for patients with Depression

View all

Haematology Clinical Guidelines

Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection

Aidsinfo

British HIV Association guidelines for the treatment of TB/HIV coinfection 2011

British HIV Association

View all

Haematology Clinical Trials

Dasatinib in Patients With Chronic Myeloid Leukemia in Chronic Phase (DASAPOST)

Clinicaltrials.gov 27 February 2013

A Phase 3, Randomized, Double-Blind, Placebo Controlled Study of the Efficacy and Safety of FG-4592 for the Treatment of Anemia in Chronic Kidney Disease Patients not on Dialysis

Clinical Trials Register.eu 05 February 2013

View all

Haematology Medical Journal Abstracts

PedsQL™ Sickle Cell Disease Module: Feasibility, Reliability, and Validity

Pediatric Blood & Cancer 25 February 2013

Validation of Variants in SLC28A3 and UGT1A6 as Genetic Markers Predictive of Anthracycline-Induced Cardiotoxicity in Children

Pediatric Blood & Cancer 25 February 2013

View all

Haematology Medical Apps

The Oncologist

Free

ACP PIER Database - Hematology

£37.29